A new IMA paper in Frontiers in Medicine (so great to see our research in other journals) charts a path for diagnosing Post-Acute COVID-19 Vaccination Syndrome, or PACVS, by proposing biomarkers, protocols, and a practical clinical framework.
The paper proposes a diagnostic framework for PACVS based on emerging biomarker evidence and a patient-centered approach. It calls for measurable criteria to differentiate PACVS from post-infection syndromes and outlines tools that may one day anchor clinical diagnosis.
“This technique offers a molecular-based endpoint of defining whether chronic spike antigenemia occurs as a result of prior infection or continued expression of vaccine-induced spike.” —Study Authors
Among the 16 autoantibodies tested, several were notably associated with clinical symptoms:
Anti-ATR1: lymphadenopathy and tonsillitis
Anti-ACE2: rash, edema, and ecchymosis
Anti-MAS1: systemic burning sensations
Anti-STAB1: skin edema and rash
Anti-ADRA2A: inversely related to cognitive symptoms like brain fog and memory loss
I have had a very itchy scalp which the dermatologist says doesn’t look like any of the typical things like dandruff or psoriasis. I wondered if any practitioners have seen this symptom in people with PACVS.
Thank you for that @qofmiwok … you question about your scalp is interesting, I suggest you scroll to the bottom of the study on Frontiers in Medicine and see the contact details for Dr. Varon, use that to submit your question to him.